Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Short term Debt: 2015-2024

Historic Short term Debt for Nutex Health (NUTX) over the last 10 years, with FY2024 value amounting to $14.4 million.

  • Nutex Health's Short term Debt rose 7147.43% to $18.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.0 million, marking a year-over-year increase of 7147.43%. This contributed to the annual value of $14.4 million for FY2024, which is 3317.95% up from last year.
  • As of FY2024, Nutex Health's Short term Debt stood at $14.4 million, which was up 3317.95% from $10.8 million recorded in FY2023.
  • In the past 5 years, Nutex Health's Short term Debt registered a high of $14.4 million during FY2024, and its lowest value of $30000.0 during FY2020.
  • Its 5-year average for Short term Debt is $9.6 million, with a median of $10.8 million in 2023.
  • As far as peak fluctuations go, Nutex Health's Short term Debt crashed by 9857.96% in 2020, and later skyrocketed by 3376310.67% in 2021.
  • Over the past 5 years, Nutex Health's Short term Debt (Annual) stood at $30000.0 in 2020, then surged by 33763.11% to $10.2 million in 2021, then grew by 23.5% to $12.5 million in 2022, then dropped by 13.85% to $10.8 million in 2023, then soared by 33.18% to $14.4 million in 2024.
  • Its last three reported values are $14.4 million in FY2024, $10.8 million for FY2023, and $12.5 million during FY2022.